Avoro Capital Advisors LLC Kodiak Sciences Inc. Transaction History

Avoro Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$13.9 - $76.65 $6.95 Million - $38.3 Million	-500,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$10.24 - $17.57 $788,695 - $1.35 Million	-77,021 Reduced 13.35%	500,000 $7.19 Million
Q2 2019 Aug 14, 2019	SELL	$6.2 - $12.0 $310,000 - $600,000	-50,000 Reduced 7.97%	577,021 $6.75 Million
Q1 2019 May 15, 2019	SELL	$6.43 - $9.44 $1.77 Million - $2.6 Million	-275,179 Reduced 30.5%	627,021 $4.09 Million
Q4 2018 Feb 14, 2019	BUY	$6.11 - $10.43 $5.51 Million - $9.41 Million	902,200 New	902,200 $6.41 Million

104

39.8M

7.6K

3.5K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.